Firms
Theme

ESI

Element Solutions Inc. · NYSE

News

4 latest

Zacks Investment Research

Zacks Industry Outlook Highlights Element Solutions, Perimeter Solutions and Quaker Chemical

The Zacks Chemicals Specialty industry faces headwinds from weak demand in Europe and China, elevated input costs, and tariff disruptions, pressuring profit margins. However, three specialty chemical companies—Element Solutions, Perimeter Solutions, and Quaker Chemical—are implementing strategic cost-cutting and productivity measures to navigate the challenging environment. The industry ranks #166 out of 250 Zacks industries and has underperformed the S&P 500 over the past year, though valuations remain attractive relative to the broader market.

Zacks Investment Research

Element Solutions (ESI) Surpasses Q3 Earnings and Revenue Estimates

Element Solutions reported Q3 2026 earnings of $0.50 per share, beating consensus estimates of $0.48, with revenues of $995.3 million exceeding expectations by 2.82%. The company has outperformed the S&P 500 by 30% year-to-date. However, the stock received a Zacks Rank #3 (Hold) rating due to mixed estimate revisions, and the Chemical - Specialty industry ranks in the bottom 34% of sectors, which may limit near-term upside.

Zacks Investment Research

Why Element Solutions (ESI) Could Beat Earnings Estimates Again

Element Solutions (ESI), a specialty chemical and printing products company, demonstrates a strong track record of beating earnings estimates with an average surprise of 8.60% over the last two quarters. The company's positive Earnings ESP of +2.08% combined with its Zacks Rank #3 (Hold) suggests another earnings beat is likely for its October 21, 2026 report.

Mentions ESI

Zacks Investment Research

Is NGVT Positioned for Further Adjusted EBITDA Improvement?

Ingevity Corporation (NGVT) reported Q2 adjusted EBITDA of $115 million, up from $101 million year-over-year, driven by higher pricing, favorable product mix, and increased volumes. The company raised its 2026 adjusted EBITDA guidance to $380-$400 million and adjusted EPS outlook to $5-$5.45. NGVT stock has gained 26.3% over the past year and trades at a forward P/S multiple of 2.1, below the industry average of 2.45X.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $ESI · 0 threads

Sign in to post on $ESI

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev